γ-Tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/EBPβ and NF-κB in macrophages

Sica, 2008, Cancer related inflammation: the macrophage connection, Cancer Lett, 267, 204, 10.1016/j.canlet.2008.03.028 Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 Park, 2010, Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, 140, 197, 10.1016/j.cell.2009.12.052 Woodrick, 2010, Anti-interleukin-6 therapy in rheumatoid arthritis, Bull NYU Hosp Jt Dis, 68, 211 Bannwarth, 2011, Clinical safety of tocilizumab in rheumatoid arthritis, Expert Opin Drug Saf, 10, 123, 10.1517/14740338.2011.537256 Jiang, 2001, γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention, Am J Clin Nutr, 74, 714, 10.1093/ajcn/74.6.714 Brigelius-Flohe, 1999, Vitamin E, function and metabolism, FASEB J, 13, 1145, 10.1096/fasebj.13.10.1145 Reiter, 2007, Anti-inflammatory properties of alpha- and gamma-tocopherol, Mol Aspects Med, 28, 668, 10.1016/j.mam.2007.01.003 Jiang, 2000, γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells, Proc Natl Acad Sci USA, 97, 11494, 10.1073/pnas.200357097 Jiang, 2008, Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases, Proc Natl Acad Sci USA, 105, 20464, 10.1073/pnas.0810962106 Jiang, 2003, γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats, FASEB J, 17, 816, 10.1096/fj.02-0877com Jiang, 2011, Natural forms of vitamin E and 13′-carboxychromanol, a long-chain vitamin E metabolite, inhibit leukotriene generation from stimulated neutrophils by blocking calcium influx and suppressing 5-lipoxygenase activity, respectively, J Immunol, 186, 1173, 10.4049/jimmunol.1002342 Wagner, 2007, Ozone enhancement of lower airway allergic inflammation is prevented by γ-tocopherol, Free Radic Biol Med, 43, 1176, 10.1016/j.freeradbiomed.2007.07.013 Wang, 2011, Vitamin E forms inhibit IL-13/STAT6-induced eotaxin-3 secretion by up-regulation of PAR4, an endogenous inhibitor of atypical PKC in human lung epithelial cells, J Nutr Biochem Moscat, 2006, PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways, Cell Death Differ, 13, 702, 10.1038/sj.cdd.4401823 Yam, 2009, Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages, Lipids, 44, 787, 10.1007/s11745-009-3326-2 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Jiang, 2004, γ-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis, Proc Natl Acad Sci USA, 101, 17825, 10.1073/pnas.0408340102 Zhang, 2008, The isolation and characterization of murine macrophages, Curr Protoc Immunol, 10.1002/0471142735.im1401s83 Wang D, and Dubois RN. Eicosanoids and cancer. Nature reviews. Cancer. 10: 181–193. Grishin, 2006, Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway, J Immunol, 176, 580, 10.4049/jimmunol.176.1.580 Dean, 1999, p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes, J Biol Chem, 274, 264, 10.1074/jbc.274.1.264 Hoffmann, 2006, Circuitry of nuclear factor κB signaling, Immunol Rev, 210, 171, 10.1111/j.0105-2896.2006.00375.x Mogensen, 2009, Pathogen recognition and inflammatory signaling in innate immune defenses, Clin Microbiol Rev, 22, 240, 10.1128/CMR.00046-08 Sanceau, 1991, IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma., J Immunol, 147, 2630, 10.4049/jimmunol.147.8.2630 Isshiki, 1990, Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene, Mol Cell Biol, 10, 2757, 10.1128/MCB.10.6.2757 Asschert, 1999, Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines, Int J Cancer, 82, 244, 10.1002/(SICI)1097-0215(19990719)82:2<244::AID-IJC15>3.0.CO;2-N Patestos, 1993, Activation of the nuclear factor kappa B is not sufficient for regulation of tumor necrosis factor-induced interleukin-6 gene expression, Biochimie, 75, 1007, 10.1016/0300-9084(93)90153-J Akira, 1990, A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family, EMBO J, 9, 1897, 10.1002/j.1460-2075.1990.tb08316.x Matsusaka, 1993, Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8, Proc Natl Acad Sci USA, 90, 10193, 10.1073/pnas.90.21.10193 Bradley, 2003, C/EBPβ regulation in lipopolysaccharide-stimulated macrophages, Mol Cell Biol, 23, 4841, 10.1128/MCB.23.14.4841-4858.2003 Su, 2003, Differential activation of a C/EBPβ isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene, J Biol Chem, 278, 51150, 10.1074/jbc.M305501200 Litvak, 2009, Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals, Nat Immunol, 10, 437, 10.1038/ni.1721 Tanaka, 1995, Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages, Cell, 80, 353, 10.1016/0092-8674(95)90418-2 Mahalingam, 2011, Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers, Eur J Clin Nutr, 65, 63, 10.1038/ejcn.2010.184 Poli, 1998, The role of C/EBP isoforms in the control of inflammatory and native immunity functions, J Biol Chem, 273, 29279, 10.1074/jbc.273.45.29279 Screpanti, 1995, Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice, EMBO J, 14, 1932, 10.1002/j.1460-2075.1995.tb07185.x Marigo, 2010, Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor, Immunity, 32, 790, 10.1016/j.immuni.2010.05.010 Gorgoni, 2002, C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages, J Immunol, 168, 4055, 10.4049/jimmunol.168.8.4055 Uematsu, 2002, Lipopolysaccharide-dependent prostaglandin E(2) production is regulated by the glutathione-dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway, J Immunol, 168, 5811, 10.4049/jimmunol.168.11.5811 Lu, 2009, Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines, J Immunol, 182, 7212, 10.4049/jimmunol.0802971 Rego, 2011, J Immunol, 186, 5443, 10.4049/jimmunol.1003551 Ahn, 2007, Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis, J Biol Chem, 282, 809, 10.1074/jbc.M610028200 Kunnumakkara, 2010, γ-Tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment, Cancer Res, 70, 8695, 10.1158/0008-5472.CAN-10-2318 Freiser, 2009, Gamma-tocotrienol and gamma-tocopherol are primarily metabolized to conjugated 2-(beta-carboxyethyl)-6-hydroxy-2,7,8-trimethylchroman and sulfated long-chain carboxychromanols in rats, J Nutr, 139, 884, 10.3945/jn.108.103309 Qureshi, 2010, Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice, Lipids Health Dis, 9, 143, 10.1186/1476-511X-9-143